Stockreport

Regeneron Pharma Jumps On Consensus-Smashing Quarter [Investor's Business Daily]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Technology Related news 2/07/2018 Sanofi and Regeneron's Dupixent is off to a strong start in the U.S., but revenue from the eczema drug lagged... Why This Former Bio [Read more]